Cargando…
Aberrant Methylation Inactivates Transforming Growth Factor β Receptor I in Head and Neck Squamous Cell Carcinoma
Background. Alterations in TGF-β signaling are common in head and neck cancer (HNSCC). Mutations in TGF-β type II receptor (T β R-II) occur frequently in HNSCC while TGF-β type I receptor (T β R-I) mutations are rare, suggesting that other molecular alterations in the TGF-β pathway are likely. To id...
Autores principales: | Muñoz-Antonia, Teresita, Torrellas-Ruiz, Mariclara, Clavell, Jonathan, Mathews, Linda A., Muro-Cacho, Carlos A., Báez, Adriana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809419/ https://www.ncbi.nlm.nih.gov/pubmed/20111589 http://dx.doi.org/10.1155/2009/848695 |
Ejemplares similares
-
Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2015) -
An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Chen, Dayang, et al.
Publicado: (2021) -
Clinical Significance of CUB and Sushi Multiple Domains 1 Inactivation in Head and Neck Squamous Cell Carcinoma
por: Jung, Ah Ra, et al.
Publicado: (2018) -
Aberrant expression of cyclin A in head and neck cancer
por: Lotayef, M, et al.
Publicado: (2000) -
Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing
por: Sakai, Akihiro, et al.
Publicado: (2020)